CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
Open Access
- 24 September 1999
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 81 (4) , 672-676
- https://doi.org/10.1038/sj.bjc.6690746
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Evidence for Autosomal Dominant Inheritance of Prostate CancerAmerican Journal of Human Genetics, 1998
- Association of Prostate Cancer Risk With Genetic Polymorphisms in Vitamin D Receptor and Androgen ReceptorJNCI Journal of the National Cancer Institute, 1997
- Family History and Prostate Cancer RiskAmerican Journal of Epidemiology, 1996
- Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide SearchScience, 1996
- Evidence of an X-linked or recessive genetic component to prostate cancer riskNature Medicine, 1995
- Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathiesHuman Molecular Genetics, 1995
- The impact of family history on early detection of prostate cancerNature Medicine, 1995
- Prostate cancer risk in U.S. blacks and whites with a family history of cancerInternational Journal of Cancer, 1995
- Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cellsThe Prostate, 1994
- Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophyNature, 1991